Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | AZN | AMGN | GILD | BMY |
| Company | Nantkwest Inc CS | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 30.34 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 33.15 | 185.19 | 326.79 | 132.89 | 58.00 |
| Low | 29.74 | 183.78 | 323.21 | 130.00 | 56.93 |
| Latest | 32.49 | 184.08 | 324.95 | 132.47 | 57.32 |
| Change | +4.21 | -0.66 | -4.87 | +0.82 | -0.90 |
| % Change | +14.89% | -0.36% | -1.48% | +0.62% | -1.55% |
| Volume | 1,109,000 | 321,750 | 676,978 | 1,937,476 | 2,956,652 |
| 20-Day Average Volume | 1,620,320 | 1,973,521 | 2,478,357 | 5,238,698 | 9,581,630 |
| Previous Close | 28.28 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 195.84 | 345.11 | 135.17 | 58.64 |
| 20-Day Raw Stochastic | 41.94% | 11.89% | 2.68% | 29.21% | 7.44% |
| 20-Day Relative Strength | 58.89 | 39.58 | 35.90 | 42.20 | 45.52 |
| Weighted Alpha | +342.67 | +29.30 | +15.08 | +28.34 | +23.54 |
| Today's Opinion | 100% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 80% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | -1.46% since 04/27/26 | -4.70% since 04/27/26 | +3.42% since 04/27/26 | -0.94% since 04/27/26 |
| Low | 23.15 on 03/05/21 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.96 on 04/30/26 | 56.95 on 05/04/26 |
| High | 33.15 on 03/09/21 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 132.89 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | -9.20% since 04/02/26 | -6.83% since 04/02/26 | -5.43% since 04/02/26 | -3.97% since 04/02/26 |
| Low | 23.15 on 03/05/21 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.95 on 05/04/26 |
| High | 45.42 on 02/22/21 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | -1.43% since 02/04/26 | -11.47% since 02/04/26 | -9.65% since 02/04/26 | -0.67% since 02/04/26 |
| Low | 10.00 on 12/10/20 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 45.42 on 02/22/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | +12.62% since 11/04/25 | +9.26% since 11/04/25 | +7.41% since 11/04/25 | +25.54% since 11/04/25 |
| Low | 6.51 on 09/11/20 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 45.42 on 02/22/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 109,345 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 110,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -92,380,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 20,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -32,140,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.38 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/24/21 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |